ZNF573

protein-coding

zinc finger protein 573, the group of Zinc fingers C2H2-type

Gene summary

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]

MANE transcript

NM_001172690.2

Inheritance

—

ClinVar variants

U:92B:7

Top phenotype

—

gnomAD constraint

pLI —, LoF o/e 0.87

Max pathogenic AF

—

Genomic locus

chr19:37,735,833-37,817,300

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~81.5 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

No GenCC data available for this gene.

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to ZNF573 variants in ClinVar

2 Conditions Cataloged
not specifiedTotal: 96
not providedTotal: 3

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_001172690.2. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
3
missense
92
clinvar
4
clinvar
96
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total00927099
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 44 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_001172690.2RefSeqNP_001166161.14MANE Select
ENST00000536220.7EnsemblENSP00000440464.24MANE Select
NM_001172689.2RefSeqNP_001166160.12Standard
NM_001172691.2RefSeqNP_001166162.14Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Gene expression (Transcription)
  • Generic Transcription Pathway
  • RNA Polymerase II Transcription

Biological Process

  • regulation of transcription, DNA-templated

Molecular Function

  • DNA binding
  • metal ion binding

Cellular Component

  • nucleus

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000590414
Coding exons
4
Length
81207
Individuals with no LoFs
125649
Homozygous LoFs
0
Heterozygous LoFs
92
Defined
125741
p
0.000366
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.3513283460.9470.00001634423
Missense (PolyPhen)122116.771.04481486
Synonymous0.6921061150.9180.000005291142
Loss of Function0.5371820.60.8729.26e-7328

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000190.00018rare
Latino/Admixed American0.000350.00035rare
Ashkenazi Jewish0.000100.000099rare
East Asian0.00100.00098rare
Finnish0.0000920.000092rare
European (Non-Finnish)0.000220.00022rare
South Asian0.000880.00088rare
Other0.000660.00065rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: May be involved in transcriptional regulation.;

Intolerance Scores

LoFtool
0.976
RVIS EVS
0.09
RVIS percentile EVS
60.57

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Indispensability pred.
N
Indispensability score
0.146

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.